AzTrials
AzTrials

Ridge AugmentationNCT05731063

Computer Guided Simultaneous Implant Placement With Tri-cortical Ridge Augmentation Using Chin Cortical Bone Struts in Anterior Atrophic Maxilla: A Case Series

A study testing Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts in people with Ridge Augmentation, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

10 patients having deficient anterior maxilla will be recruited and a preoperative CBCT will be done to evaluate the vertical and horizontal dimensions of the intended alveolar ridge. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ridge Augmentation
What is being tested?
Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteEgypt
Study dates
27 Aug 2023to 26 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with single or Multiple missing Maxillary Anterior Teeth with vertically and horizontally defective ridges having adequate soft tissue ample.
  • Patients who gave their consent for this trial.
  • Males and females will be included.

Who cannot join

  • Patients on bisphosphonates or drugs altering bone metabolism, within 2 months before initiating the study.
  • Subjected to irradiation in the head and neck area less than 1 year before implantation.
  • Patients allergic to drugs used in the study.
  • Patients having a history of a major medical condition (ASA 3,4)
  • Untreated periodontitis.
  • Poor oral hygiene and motivation.
Show all 17Show fewer
  • Uncontrolled diabetes.
  • Pregnant or nursing.
  • Substance abuse.
  • Psychiatric problems or unrealistic expectations.
  • Severe bruxism or clenching.
  • Immunosuppressed or immunocompromised patients.
  • Treated or under treatment with intravenous amino-bisphosphonates.
  • Active infection or severe inflammation in the area intended for implant placement.
  • Unable to open mouth sufficiently to accommodate the surgical tooling.
  • Patients participating in other studies, if the present protocol could not be properly followed.
  • Referred only for implant placement or unable to attend a 5-year follow-up.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Dentistry, Cairo University

    Cairo, 11553

Other trials in Egypt

About this study

10 patients having deficient anterior maxilla will be recruited and a preoperative CBCT will be done to evaluate the vertical and horizontal dimensions of the intended alveolar ridge. pre-operative manufacturing of the digital surgical guides performed for Harvesting of the chin cortical bone struts from the symphysial area in the donor site and for Placement of the grafted cortical bone struts and the implant in the recipient site. Intra operatively the donor site (Chin) will be prepared to harvest autogenous bone from the chin aided by the patient's prefabricated bone harvesting guide. The recipient site (Maxillary anterior defect) will be prepared to receive the chin grafts. Grafts will be screwed in position and implants will be screwed in its preparation until it gains primary stability from basal bone, using the prefabricated bone fixation-implant placement guide. Any gaps will be filled with autogenous bone particulates from the chin. A healing tie base Abutment will be screwed into the implant through the third cortex.

Primary stability will be assessed using Osstell device. An immediate postoperative CBCT will be done and superimposed on the preoperative CBCT to measure accuracy of plan transfer to make sure the planning was followed accurately.

Follow up after 6 months and CBCT will be done for bone formation and density assessment and implant exposure for implant stability measurement-using osstell and removal Healing abutment and consecutive prosthetic loading.

Being tested
Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone strutsProcedure or surgery

    fabrication of surgical guide to aid in chin bone harvesting and another guide to help for accurate placement and simultaneous placement in anterior maxillary defective area.

Study groups in NCT05731063
Study groupRoleWhat they receive
Ridge augmentation surgeryOtherComputer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts in anterior atrophic maxilla
Receives: Procedure: Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bone quantity (bone formation "height and width")

    Serial CBCT scans (T0 before surgery, T1 immediately after surgery, T2 after 6 months) measuring bone quantity in mm

    Measured: T0 before surgery, T1 immediately after surgery, T2 after 6 months

Secondary outcomes (3)
  1. Implant stability

    Measure primary stability immediately after implant placement and in the second surgery using the Osstell device (ISQ value of 1-100)

    Measured: Day of the surgery and at 6 months

  2. Accuracy of Plan Transfer

    Superimposition of the preoperative digital plan and the 6-month postoperative CBCT to assess the positional discrepancy of the graft between the digital plan versus the actual postoperative position will be measured in millimeters three-dimensionally (anteroposterior, vertical, and lateral position).

    Measured: T1 immediately after surgery, T2 after 6 months

  3. Bone quality (change in bone density)

    Serial CBCT scans measuring change in bone density in grey value

    Measured: T0 before surgery, T1 immediately after surgery, T2 after 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Feb 2023
  2. Study start27 Aug 2023
  3. Primary completion26 Aug 2024
  4. Study completion26 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05731063
Sponsor's protocol ID
2722
Status last verified
Sep 2023
First submitted
14 Nov 2022
Last updated
14 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Computer guided simultaneous implant placement with tri-cortical ridge augmentation using chin cortical bone struts in people with Ridge Augmentation, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bone quantity (bone formation "height and width") (time frame: T0 before surgery, T1 immediately after surgery, T2 after 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in